Wood expands UK pharma footprint with GlaxoSmithKline contract win

Wood, the global engineering and consulting company, has been appointed as the capital delivery partner by GlaxoSmithKline (GSK) for its Ware site in Hertfordshire, UK

The 3-year contract strengthens Wood’s strategy for sector diversification in the UK and demonstrates the company’s strong track record in providing engineering and design services for more than a decade to GSK’s global sites.

Under the partnership, a Wood delivery team will provide engineering, procurement and construction management services at the site with support from the company’s engineering hub in Glasgow.

Dave Stewart, CEO of Wood’s Asset Solutions business in Europe, Africa, Asia and Australia, comments: “We are delighted to grow our longstanding relationship with GSK by partnering with them to support the development and manufacture of life-saving medicines at one of their key UK campuses."

“Our ability to provide multidisciplinary services via one project management team was key to securing this appointment, in addition to our flexible delivery model and the expertise of our specialist engineering, construction and quality control teams."

“This framework is another significant step in leveraging our global engineering capability and cross-sector experience to diversify our portfolio in the UK, specifically in the life sciences sector.”

Companies